{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T02:34:19Z","timestamp":1772505259494,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T00:00:00Z","timestamp":1326758400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T00:00:00Z","timestamp":1326758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s00277-012-1406-5","type":"journal-article","created":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T12:21:54Z","timestamp":1326716514000},"page":"1081-1089","source":"Crossref","is-referenced-by-count":34,"title":["Toxoplasmosis after allogeneic stem cell transplantation\u2014a single centre experience"],"prefix":"10.1007","volume":"91","author":[{"given":"Christoph","family":"Busemann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Ribback","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena","family":"Sailer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kiefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian A.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo","family":"Steinmetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Dombrowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gottfried","family":"D\u00f6lken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,17]]},"reference":[{"issue":"5","key":"1406_CR1","first-page":"549","volume":"13","author":"MA Slavin","year":"1994","unstructured":"Slavin MA, Meyers JD, Remington JS, Hackman RC (1994) Toxoplasma gondii infection in marrow transplant recipients: a 20\u00a0year experience. Bone Marrow Transplant 13(5):549\u2013557","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"1406_CR2","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ijantimicag.2006.04.001","volume":"27","author":"M Aoun","year":"2006","unstructured":"Aoun M, Georgala A, Mboumi K, De Bruyne JM, Duchateau V, Lemort M et al (2006) Changing the outcome of toxoplasmosis in bone marrow transplant recipients. Int J Antimicrob Agents 27(6):570\u2013572","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"1406_CR3","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/annonc\/mdi238","volume":"16","author":"WH Kruger","year":"2005","unstructured":"Kruger WH, Bohlius J, Cornely OA, Einsele H, Hebart H, Massenkeil G et al (2005) Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Oncology. Ann Oncol 16(8):1381\u20131390","journal-title":"Ann Oncol"},{"issue":"2","key":"1406_CR4","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1086\/595709","volume":"48","author":"H Fricker-Hidalgo","year":"2009","unstructured":"Fricker-Hidalgo H, Bulabois CE, Brenier-Pinchart MP, Hamidfar R, Garban F, Brion JP et al (2009) Diagnosis of toxoplasmosis after allogeneic stem cell transplantation: results of DNA detection and serological techniques. Clin Infect Dis 48(2):e9\u2013e15","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1406_CR5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1086\/426447","volume":"40","author":"R Martino","year":"2005","unstructured":"Martino R, Bretagne S, Einsele H, Maertens J, Ullmann AJ, Parody R et al (2005) Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin Infect Dis 40(1):67\u201378","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1406_CR6","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood-2002-05-1340","volume":"101","author":"D Niederwieser","year":"2003","unstructured":"Niederwieser D, Maris M, Shizuru JA, Petersdorf E, Hegenbart U, Sandmaier BM et al (2003) Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 101(4):1620\u20131629","journal-title":"Blood"},{"issue":"2","key":"1406_CR7","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1182\/blood-2002-11-3615","volume":"103","author":"J Casper","year":"2004","unstructured":"Casper J, Knauf W, Kiefer T, Wolff D, Steiner B, Hammer U et al (2004) Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation. Blood 103(2):725\u2013731","journal-title":"Blood"},{"key":"1406_CR8","first-page":"88","volume-title":"High-dose therapy and transplantation of haematopoietic stem cells (2001)","author":"N Kroger","year":"2002","unstructured":"Kroger N, Derigs G, Wandt H, Schafer-Eckart K, Wittkowsky G, Kuse R et al (2002) Low treatment-related mortality following allografting in advanced multiple myeloma after an intensified conditioning regimen and anti-thymocyte globulin for GvHD prevention. In: Schultze W (ed) High-dose therapy and transplantation of haematopoietic stem cells (2001), 1st edn. Blackwell, Berlin, pp 88\u201396","edition":"1"},{"issue":"4","key":"1406_CR9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.bmt.1702204","volume":"25","author":"AM Carella","year":"2000","unstructured":"Carella AM, Champlin R, Slavin S, McSweeney P, Storb R (2000) Mini-allografts: ongoing trials in humans. Bone Marrow Transplant 25(4):345\u2013350 [editorial]","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"1406_CR10","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1128\/JCM.27.8.1787-1792.1989","volume":"27","author":"JL Burg","year":"1989","unstructured":"Burg JL, Grover CM, Pouletty P, Boothroyd JC (1989) Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol 27(8):1787\u20131792","journal-title":"J Clin Microbiol"},{"key":"1406_CR11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2334-3-7","volume":"3","author":"U Reischl","year":"2003","unstructured":"Reischl U, Bretagne S, Kruger D, Ernault P, Costa JM (2003) Comparison of two DNA targets for the diagnosis of Toxoplasmosis by real-time PCR using fluorescence resonance energy transfer hybridization probes. BMC Infect Dis 3:7","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1406_CR12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0020-7519(99)00170-8","volume":"30","author":"WL Homan","year":"2000","unstructured":"Homan WL, Vercammen M, De BJ, Verschueren H (2000) Identification of a 200- to 300-fold repetitive 529\u00a0bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR. Int J Parasitol 30(1):69\u201375","journal-title":"Int J Parasitol"},{"issue":"5","key":"1406_CR13","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1086\/317471","volume":"31","author":"R Martino","year":"2000","unstructured":"Martino R, Maertens J, Bretagne S, Rovira M, Deconinck E, Ullmann AJ et al (2000) Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis 31(5):1188\u20131195","journal-title":"Clin Infect Dis"},{"issue":"12","key":"1406_CR14","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1469-0691.2008.02091.x","volume":"14","author":"F Derouin","year":"2008","unstructured":"Derouin F, Pelloux H (2008) Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect 14(12):1089\u20131101","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"1406_CR15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/sj.bmt.1703425","volume":"29","author":"A Mele","year":"2002","unstructured":"Mele A, Paterson PJ, Prentice HG, Leoni P, Kibbler CC (2002) Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplant 29(8):691\u2013698","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"1406_CR16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1600-0609.2007.00919.x","volume":"79","author":"Y Matsuo","year":"2007","unstructured":"Matsuo Y, Takeishi S, Miyamoto T, Nonami A, Kikushige Y, Kunisaki Y et al (2007) Toxoplasmosis encephalitis following severe graft-vs.-host disease after allogeneic hematopoietic stem cell transplantation: 17\u00a0yr experience in Fukuoka BMT group. Eur J Haematol 79(4):317\u2013321","journal-title":"Eur J Haematol"},{"issue":"5","key":"1406_CR17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1600-0463.2008.00871.x","volume":"116","author":"B Edvinsson","year":"2008","unstructured":"Edvinsson B, Lundquist J, Ljungman P, Ringden O, Evengard B (2008) A prospective study of diagnosis of Toxoplasma gondii infection after bone marrow transplantation. APMIS 116(5):345\u2013351","journal-title":"APMIS"},{"issue":"2","key":"1406_CR18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1128\/JCM.01113-09","volume":"48","author":"T Wahab","year":"2010","unstructured":"Wahab T, Edvinsson B, Palm D, Lindh J (2010) Comparison of the AF146527 and B1 repeated elements, two real-time PCR targets used for detection of Toxoplasma gondii. J Clin Microbiol 48(2):591\u2013592","journal-title":"J Clin Microbiol"},{"issue":"10","key":"1406_CR19","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","volume":"15","author":"M Tomblyn","year":"2009","unstructured":"Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J et al (2009) Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 15(10):1143\u20131238","journal-title":"Biol Blood Marrow Transplant"},{"key":"1406_CR20","first-page":"47","volume-title":"High-dose therapy and transplantation of haematopoietic stem cells","author":"N Kroger","year":"2001","unstructured":"Kroger N, Zabelina T, Kruger W, Renges H, Stute N, Schrum J et al (2001) CMV-seropositivity of the patient with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pre-transplant in vivo T-cell depletion with ATG. In: Schultze W (ed) High-dose therapy and transplantation of haematopoietic stem cells, 1st edn. Blackwell, Berlin, pp 47\u201360","edition":"1"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1406-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-012-1406-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1406-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1406-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T07:10:04Z","timestamp":1589958604000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-012-1406-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,17]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["1406"],"URL":"https:\/\/doi.org\/10.1007\/s00277-012-1406-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,17]]}}}